$WKHS
Workhorse Group Inc. Stock $wkhs

$wkhs Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023029433 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$3.029M	$3.966M
YoY Change	95.54%	31480.12%
Cost Of Revenue	$6.557M	$8.427M
YoY Change	-31.09%	179.03%
Gross Profit	-$3.529M	-$4.461M
YoY Change	-55.71%	48.32%
Gross Profit Margin	-116.52%	-112.47%
Selling, General & Admin	$11.76M	$14.00M
YoY Change	-66.17%	7.46%
% of Gross Profit
Research & Development	$5.772M	$5.060M
YoY Change	-5.8%	0.65%
% of Gross Profit
Depreciation & Amortization	$1.080M	$746.3K
YoY Change	61.67%	91.17%
% of Gross Profit
Operating Expenses	$17.53M	$19.06M
YoY Change	-57.12%	5.57%
Operating Profit	-$21.06M	-$23.52M
YoY Change	-56.89%	11.67%
Interest Expense	$410.0K	$505.5K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$10.00M
YoY Change	-174.4%
Pretax Income	-$30.65M	-$23.02M
YoY Change	-13.44%	8.78%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$30.65M	-$23.02M
YoY Change	-13.44%	8.78%
Net Earnings / Revenue	-1011.9%	-580.31%
Basic Earnings Per Share	-$0.14	-$0.12
Diluted Earnings Per Share	-$0.14	-$0.12
COMMON SHARES
Basic Shares Outstanding	210.8M shares	185.0M shares
Diluted Shares Outstanding	215.9M shares	185.7M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.90M	$62.38M
YoY Change	-67.62%	-55.46%
Cash & Equivalents	$38.90M	$62.40M
Short-Term Investments
Other Short-Term Assets	$612.8K	$827.5K
YoY Change	-0.14%	60.87%
Inventory	$40.78M	$34.62M
Prepaid Expenses
Receivables	$7.424M	$2.837M
Other Receivables	$0.00	$15.00M
Total Short-Term Assets	$97.78M	$124.3M
YoY Change	-40.08%	-24.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$37.47M	$31.30M
YoY Change	119.77%	130.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$10.00M
YoY Change	-100.0%
Other Assets	$176.3K	$176.3K
YoY Change	0.0%	39.59%
Total Long-Term Assets	$48.52M	$52.64M
YoY Change	25.37%	107.43%
TOTAL ASSETS
Total Short-Term Assets	$97.78M	$124.3M
Total Long-Term Assets	$48.52M	$52.64M
Total Assets	$146.3M	$176.9M
YoY Change	-27.53%	-7.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.94M	$10.23M
YoY Change	54.45%	170.09%
Accrued Expenses	$5.859M	$43.05M
YoY Change	-86.93%	348.61%
Deferred Revenue	$4.737M	$1.406M
YoY Change	40.35%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.87M	$58.09M
YoY Change	-57.15%	227.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.700M	$11.44M
YoY Change	-24.82%	27.98%
Total Long-Term Liabilities	$7.700M	$11.44M
YoY Change	-24.82%	27.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.87M	$58.09M
Total Long-Term Liabilities	$7.700M	$11.44M
Total Liabilities	$33.53M	$69.54M
YoY Change	-52.52%	160.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$706.3M	-$675.7M
YoY Change	19.92%	22.06%
Common Stock	$255.4K	$205.2K
YoY Change	59.17%	28.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$112.8M	$107.4M
YoY Change
Total Liabilities & Shareholders Equity	$146.3M	$176.9M
YoY Change	-27.53%	-7.14%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$30.65M	-$23.02M
YoY Change	-13.44%	8.78%
Depreciation, Depletion And Amortization	$1.080M	$746.3K
YoY Change	61.67%	91.17%
Cash From Operating Activities	-$29.75M	-$33.05M
YoY Change	182.88%	33.7%
INVESTING ACTIVITIES
Capital Expenditures	$6.060M	$5.068M
YoY Change	-249.63%	-345.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$6.060M	-$5.068M
YoY Change	-33.04%	145.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.28M	21.39M
YoY Change	-3366.65%	-10565.28%
NET CHANGE
Cash From Operating Activities	-29.75M	-33.05M
Cash From Investing Activities	-6.060M	-5.068M
Cash From Financing Activities	12.28M	21.39M
Net Change In Cash	-23.53M	-16.73M
YoY Change	17.99%	-38.0%
FREE CASH FLOW
Cash From Operating Activities	-$29.75M	-$33.05M
Capital Expenditures	$6.060M	$5.068M
Free Cash Flow	-$35.81M	-$38.12M
YoY Change	453.74%	68.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-48016713	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43214807	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-23017676	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21160272	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48016713	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43214807	usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	185660305	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	185660305	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159107776	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159107776	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	176453477	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	176453477	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	25381078	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-128226	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3292409	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-21160272	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	163828453	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174692773	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	25381078	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-324488	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5642702	usd
	us-gaap	Net Income Loss NetIncomeLoss	-43214807	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1402500	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	163828453	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	104820548	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-23017676	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	107387721	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-54369	usd
	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-425130	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	425421	usd
	wkhs	Noncash Lease Expense NoncashLeaseExpense	583406	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-200000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-175750	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	851649	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	634892	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25909707	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3187163	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4783655	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7119454	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	34401	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3783596	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9317242	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-285094	usd
	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-1261704	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65800126	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55462470	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10472730	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5658776	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10472730	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5658776	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	40291607	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	248695	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	439722	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	389780	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-475590	usd
	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-324488	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39376295	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-465573	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-36896561	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61586819	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201647394	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62379740	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140060575	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	163492	usd
	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	5700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-48000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65800000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62400000	usd
CY2023Q2	wkhs	Working Capital WorkingCapital	66200000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-675700000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period balances have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and the accompanying notes. These reclassifications have no effect on previously reported results of operations or stockholders’ equity.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2022Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-645246	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	310219	usd
	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-562746	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	26673327	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	42500878	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	25210131	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10281415	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	301645	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	36954742	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	68012654	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2331176	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	59162512	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	34623566	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8850142	usd
CY2023Q2	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	25878084	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	34611649	usd
CY2023Q2	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	17669622	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	22163338	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	8208462	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	12448311	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	414803	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1198769	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	827475	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	505401	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9450740	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14152481	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3322212	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3966463	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12555	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5659878	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26854	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4800000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	35500000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	35000000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3138072	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4967187	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4411671	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6240244	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	43049743	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	46207431	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2066588	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4315463	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4583916	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	307500	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	348005	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	595313	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	698958	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	1922580	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3322212	usd
CY2023Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	68368	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	248103	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	126675	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	424008	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	568157	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	465544	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1140497	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	762967	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	636525	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	713647	usd
	us-gaap	Lease Cost LeaseCost	1267172	usd
	us-gaap	Lease Cost LeaseCost	1186975	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5437003	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5884865	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5721559	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5821938	usd
CY2023Q2	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11158562	usd
CY2022Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11706803	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6707406	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6977896	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	2855146	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3147198	usd
CY2023Q2	wkhs	Lease Liability LeaseLiability	9562552	usd
CY2022Q4	wkhs	Lease Liability LeaseLiability	10125094	usd
CY2023Q2	wkhs	Lease Liability Current LeaseLiabilityCurrent	1486417	usd
CY2022Q4	wkhs	Lease Liability Current LeaseLiabilityCurrent	1285032	usd
CY2023Q2	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8076135	usd
CY2022Q4	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8840062	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	17500000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3100000	shares
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3777096	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5642702	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	423626	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.6
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.8
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	70997	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.8
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	352429	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	204213	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	7.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	24300000	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	38680000	shares
CY2023Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	21700000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	40300000	usd
CY2023Q2	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	120700000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100000	shares
CY2022Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	200000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	200000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-23-029433-index-headers.html	Edgar Link	pending
0001628280-23-029433-index.html	Edgar Link	pending
0001628280-23-029433.txt	Edgar Link	pending
0001628280-23-029433-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
floorplanandsecurityagre.htm	Edgar Link	pending
floorplanandsecurityagre001.jpg	Edgar Link	pending
floorplanandsecurityagre002.jpg	Edgar Link	pending
floorplanandsecurityagre003.jpg	Edgar Link	pending
floorplanandsecurityagre004.jpg	Edgar Link	pending
floorplanandsecurityagre005.jpg	Edgar Link	pending
floorplanandsecurityagre006.jpg	Edgar Link	pending
floorplanandsecurityagre007.jpg	Edgar Link	pending
floorplanandsecurityagre008.jpg	Edgar Link	pending
floorplanandsecurityagre009.jpg	Edgar Link	pending
floorplanandsecurityagre010.jpg	Edgar Link	pending
floorplanandsecurityagre011.jpg	Edgar Link	pending
floorplanandsecurityagre012.jpg	Edgar Link	pending
floorplanandsecurityagre013.jpg	Edgar Link	pending
floorplanandsecurityagre014.jpg	Edgar Link	pending
floorplanandsecurityagre015.jpg	Edgar Link	pending
floorplanandsecurityagre016.jpg	Edgar Link	pending
floorplanandsecurityagre017.jpg	Edgar Link	pending
floorplanandsecurityagre018.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20230630.htm	Edgar Link	pending
wkhs-20230630.xsd	Edgar Link	pending
wkhs-20230630xexx311.htm	Edgar Link	pending
wkhs-20230630xexx312.htm	Edgar Link	pending
wkhs-20230630xexx321.htm	Edgar Link	pending
wkhs-20230630xexx322.htm	Edgar Link	pending
wkhs-20230630_cal.xml	Edgar Link	unprocessable
wkhs-20230630_lab.xml	Edgar Link	unprocessable
wkhs-20230630_def.xml	Edgar Link	unprocessable
wkhs-20230630_pre.xml	Edgar Link	unprocessable
wkhs-20230630_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKHS
Workhorse Group Inc. Stock $wkhs

2023 Q3 Form 10-Q Financial Statement

#000162828023029433 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS Workhorse Group Inc. Stock $wkhs

2023 Q3 Form 10-Q Financial Statement

#000162828023029433 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS
Workhorse Group Inc. Stock $wkhs